ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Acadia Pharmaceut Dl 01

Acadia Pharmaceut Dl 01 (0A4W)

0,00
0,00
( 0,00% )
Aktualisiert: -

Acadia Pharmaceut Dl 01 (0A4W) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-06-26Mr. James K. KiharaSVP of Finance-11,42k297,91kAutomatic Disposition26,0813,09k-46,60%
2026-05-29Ms. Laura A. BregeIndependent Director8,11k0,00Derivative Exercise and Retained Stock-23,20k53,71%
2026-05-29Mr. James M. DalyIndependent Director8,11k0,00Derivative Exercise and Retained Stock-12,15k200,62%
2026-05-29Dr. Edmund P. HarriganIndependent Director8,11k0,00Derivative Exercise and Retained Stock-43,15k23,14%
2026-05-29Mr. Jonathan M. PooleIndependent Director2,01k0,00Derivative Exercise and Retained Stock-2,01k-
2026-05-29Dr. Elizabeth A. GarofaloIndependent Director8,11k0,00Derivative Exercise and Retained Stock-33,49k31,94%
2026-05-29Dr. Adora NduIndependent Director8,11k0,00Derivative Exercise and Retained Stock-32,91k32,69%
2026-05-26Mr. James K. KiharaSVP of Finance-5,40k114,39kVerkauf21,1824,51k-18,06%
2026-05-01Mr. Mark C. SchneyerExec. VP & CFO3,31k0,00Derivative Exercise and Retained Stock-66,15k5,27%
2026-05-01Mr. Mark C. SchneyerExec. VP & CFO-3,51k76,40kDerivative Exercise and Sale21,7966,15k-
2026-05-01Mr. James K. KiharaSVP of Finance1,26k0,00Derivative Exercise and Retained Stock-29,13k4,54%
2026-05-01Mr. James K. KiharaSVP of Finance-1,33k29,02kDerivative Exercise and Sale21,7929,13k-
2026-04-05Mr. Mark C. SchneyerExec. VP & CFO2,57k0,00Derivative Exercise and Retained Stock-62,84k4,26%
2026-04-05Mr. Mark C. SchneyerExec. VP & CFO-2,71k60,14kDerivative Exercise and Sale22,2062,84k-
2026-04-05Mr. James K. KiharaSVP of Finance980,000,00Derivative Exercise and Retained Stock-27,87k3,65%
2026-04-05Mr. James K. KiharaSVP of Finance-1,03k22,87kDerivative Exercise and Sale22,2027,87k-
2026-03-24Mr. James K. KiharaSVP of Finance1,83k0,00Derivative Exercise and Retained Stock-26,89k7,29%
2026-03-24Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary-3,84k82,53kDerivative Exercise and Sale21,4711,28k-
2026-03-24Mr. Mark C. SchneyerExec. VP & CFO-7,39k159,14kDerivative Exercise and Sale21,47 - 21,7260,27k-
2026-03-24Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary3,67k0,00Derivative Exercise and Retained Stock-11,28k48,25%
2026-03-24Mr. Mark C. SchneyerExec. VP & CFO6,93k0,00Derivative Exercise and Retained Stock-60,27k12,99%
2026-03-24Ms. Catherine E. Owen AdamsCEO & Director-11,64k249,93kDerivative Exercise and Sale21,4714,80k-
2026-03-24Dr. Elizabeth H. Z. ThompsonExec. VP and Head of Research & Development-3,44k73,75kDerivative Exercise and Sale21,473,28k-
2026-03-24Dr. Elizabeth H. Z. ThompsonExec. VP and Head of Research & Development3,28k0,00Derivative Exercise and Retained Stock-3,28k-
2026-03-24Mr. James K. KiharaSVP of Finance-1,94k41,90kDerivative Exercise and Sale21,47 - 21,7326,89k-
2026-03-24Ms. Catherine E. Owen AdamsCEO & Director11,87k0,00Derivative Exercise and Retained Stock-14,80k404,36%
2026-02-06Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary5,99k0,00Derivative Exercise and Retained Stock-7,61k371,15%
2026-02-06Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary-6,95k162,49kDerivative Exercise and Sale23,387,61k-
2025-11-17Mr. Mark C. SchneyerExec. VP & CFO9,56k0,00Derivative Exercise and Retained Stock-53,34k21,85%
2025-11-17Mr. Mark C. SchneyerExec. VP & CFO-10,26k243,11kDerivative Exercise and Sale23,6953,34k-
2025-11-17Mr. James K. KiharaSVP of Finance3,85k0,00Derivative Exercise and Retained Stock-25,06k18,14%
2025-11-17Mr. James K. KiharaSVP of Finance-4,08k96,75kDerivative Exercise and Sale23,6925,06k-
2025-11-10Mr. James M. DalyIndependent Director-30,00k670,98kVerkauf22,374,04k-88,13%
2025-09-15Mr. Mark C. SchneyerExec. VP & CFO-3,50k82,73kAutomatic Disposition23,6543,45k-7,45%
2025-09-02Dr. Elizabeth A. GarofaloIndependent Director-1,60k41,56kVerkauf25,9825,38k-5,93%
2025-08-18Mr. Mark C. SchneyerExec. VP & CFO-22,00k554,02kAutomatic Disposition25,1840,13k-35,41%